SG11201404061YA - New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor - Google Patents

New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor

Info

Publication number
SG11201404061YA
SG11201404061YA SG11201404061YA SG11201404061YA SG11201404061YA SG 11201404061Y A SG11201404061Y A SG 11201404061YA SG 11201404061Y A SG11201404061Y A SG 11201404061YA SG 11201404061Y A SG11201404061Y A SG 11201404061YA SG 11201404061Y A SG11201404061Y A SG 11201404061YA
Authority
SG
Singapore
Prior art keywords
dihydropyrrolo
imidazolyl
salts
new forms
aromatase inhibitor
Prior art date
Application number
SG11201404061YA
Other languages
English (en)
Inventor
Paul Sutton
Eric Loeser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47604250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201404061Y(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SG11201404061YA publication Critical patent/SG11201404061YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG11201404061YA 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor SG11201404061YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261587280P 2012-01-17 2012-01-17
PCT/US2013/021521 WO2013109514A1 (en) 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor

Publications (1)

Publication Number Publication Date
SG11201404061YA true SG11201404061YA (en) 2014-08-28

Family

ID=47604250

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201404061YA SG11201404061YA (en) 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor

Country Status (40)

Country Link
US (2) US9334276B2 (cs)
EP (1) EP2804863B1 (cs)
JP (1) JP5749410B2 (cs)
KR (2) KR20140141687A (cs)
CN (1) CN104039793B (cs)
AP (1) AP2014007762A0 (cs)
AR (1) AR089728A1 (cs)
AU (1) AU2013209952B2 (cs)
BR (1) BR112014017260A8 (cs)
CA (1) CA2863339C (cs)
CL (1) CL2014001863A1 (cs)
CO (1) CO7000775A2 (cs)
CR (1) CR20140345A (cs)
CU (1) CU20140086A7 (cs)
CY (1) CY1117914T1 (cs)
DK (1) DK2804863T3 (cs)
EA (1) EA026232B1 (cs)
ES (1) ES2564143T3 (cs)
GT (1) GT201400155A (cs)
HR (1) HRP20160178T1 (cs)
HU (1) HUE026984T2 (cs)
IL (1) IL233541B (cs)
IN (1) IN2014DN06781A (cs)
JO (1) JO3137B1 (cs)
MA (1) MA35858B1 (cs)
MX (1) MX2014008686A (cs)
NZ (1) NZ626277A (cs)
PE (1) PE20142358A1 (cs)
PH (1) PH12014501638B1 (cs)
PL (1) PL2804863T3 (cs)
RS (1) RS54589B1 (cs)
SG (1) SG11201404061YA (cs)
SI (1) SI2804863T1 (cs)
SM (1) SMT201600083B (cs)
TN (1) TN2014000256A1 (cs)
TW (1) TWI609869B (cs)
UA (1) UA114803C2 (cs)
UY (1) UY34576A (cs)
WO (1) WO2013109514A1 (cs)
ZA (1) ZA201404314B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX354022B (es) * 2010-01-14 2018-02-08 Novartis Ag Uso de un agente modificador de hormonas suprarrenales.
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
WO2016005880A1 (en) 2014-07-07 2016-01-14 Novartis Ag Pharmaceutical dosage forms
PL3250555T3 (pl) * 2015-01-29 2021-08-02 Recordati Ag Sposób wytwarzania skondensowanych pochodnych imidazolu
WO2016164476A2 (en) * 2015-04-06 2016-10-13 Millendo Therapeutics, Inc. Combination therapy for treating disorders associated with excess cortisol production
CN109890389B (zh) * 2016-10-27 2022-07-01 达米安制药股份公司 醛固酮合酶抑制剂
WO2018078049A1 (en) * 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
JP7470050B2 (ja) 2018-05-03 2024-04-17 ダミアン ファーマ アーゲー アルドステロン症の治療における使用のためのr-ファドロゾール

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1315449A (en) * 1918-11-15 1919-09-09 Frank B Yingling Shaper-feed.
US4617307A (en) 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5066656A (en) 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
MTP1076B (en) 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate
DE69330557T2 (de) 1992-01-27 2002-06-20 Janssen Pharmaceutica N.V., Beerse Pyrroloimidazolyl und imidazopyridinyl substituierte 1h-benzimidazolderivate als aromatase inhibitoren
PT1565463E (pt) * 2002-11-18 2008-09-10 Novartis Ag Derivados de imidazo[1,5-a]piridina e métodos para tratar doenças mediadas pela aldosterona
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
BRPI0721290A2 (pt) 2006-12-18 2014-03-25 Novartis Ag Compostos orgânicos
WO2011064376A1 (en) 2009-11-30 2011-06-03 Novartis Ag Imidazole derivatives as aldosterone synthase inhibitors
MX354022B (es) * 2010-01-14 2018-02-08 Novartis Ag Uso de un agente modificador de hormonas suprarrenales.

Also Published As

Publication number Publication date
AP2014007762A0 (en) 2014-07-31
CN104039793A (zh) 2014-09-10
BR112014017260A2 (pt) 2017-06-13
JP2015503627A (ja) 2015-02-02
MX2014008686A (es) 2014-08-27
HRP20160178T1 (hr) 2016-03-25
HUE026984T2 (en) 2016-08-29
KR20140093726A (ko) 2014-07-28
NZ626277A (en) 2015-10-30
MA35858B1 (fr) 2014-12-01
US9334276B2 (en) 2016-05-10
DK2804863T3 (en) 2016-03-07
AU2013209952A1 (en) 2014-07-24
CR20140345A (es) 2014-09-09
US20160176883A1 (en) 2016-06-23
SMT201600083B (it) 2016-04-29
ES2564143T8 (es) 2020-11-18
BR112014017260A8 (pt) 2017-07-04
EP2804863A1 (en) 2014-11-26
AR089728A1 (es) 2014-09-10
CU20140086A7 (es) 2014-12-26
RS54589B1 (en) 2016-08-31
PE20142358A1 (es) 2015-01-30
IL233541B (en) 2018-12-31
CA2863339A1 (en) 2013-07-25
EA026232B1 (ru) 2017-03-31
EP2804863B1 (en) 2015-12-02
CO7000775A2 (es) 2014-07-21
JO3137B1 (ar) 2017-09-20
KR20140141687A (ko) 2014-12-10
TN2014000256A1 (en) 2015-09-30
TWI609869B (zh) 2018-01-01
UA114803C2 (uk) 2017-08-10
ZA201404314B (en) 2015-08-26
CY1117914T1 (el) 2017-05-17
AU2013209952B2 (en) 2016-09-01
CN104039793B (zh) 2017-05-10
WO2013109514A1 (en) 2013-07-25
SI2804863T1 (sl) 2016-05-31
EA201491374A1 (ru) 2014-12-30
PL2804863T3 (pl) 2016-06-30
TW201335161A (zh) 2013-09-01
CA2863339C (en) 2021-03-23
HK1198536A1 (en) 2015-05-15
IN2014DN06781A (cs) 2015-05-22
US20140364470A1 (en) 2014-12-11
PH12014501638A1 (en) 2014-10-13
UY34576A (es) 2013-09-02
IL233541A0 (en) 2014-08-31
CL2014001863A1 (es) 2014-11-07
GT201400155A (es) 2017-09-28
ES2564143T3 (es) 2016-03-18
PH12014501638B1 (en) 2014-10-13
JP5749410B2 (ja) 2015-07-15

Similar Documents

Publication Publication Date Title
IL233541A0 (en) Salts and forms of dihydropyrrolo[1,2-c] imidazole aldosterone synthase or aromatase inhibitor
GB2498145B (en) Releasable corrosion inhibitors
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
ZA201308198B (en) Combinations of akt inhibitor compounds and abiraterone, and methods of use
EP2552208A4 (en) IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS
IL221823A (en) Pipridine-4-Il-Aztidine Derivatives as Jack 1 Suppressors
EP2776837A4 (en) COMBINATION OF KINASEINHIBITORS AND THEIR USE
EP2552214A4 (en) PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
EP2552211A4 (en) INDAZOLYL-PYRIMIDINE AS KINASEHEMMER
IL221311A0 (en) Inhibitors of protein kinases
GB201009731D0 (en) Kinase inhibitors
GB201016880D0 (en) Phosphodiesterase inhibitors
ZA201206456B (en) Uses of dgati inhibitors
IL225605A0 (en) Polo-like kinase inhibitors
SG11201404654SA (en) Tetrahydro-quinazolinone derivatives as tank and parp inhibitors
ZA201300036B (en) Banzamide derivatives and their use as hsp90 inhibitors
ZA201208895B (en) Bicyclic compound derivatives and their use as acc inhibitors
GB201020798D0 (en) Corrosion inhibitors
GB201219678D0 (en) Ketone body inhibitors and uses thereof
IL222379A0 (en) Kras primers and probes
PL2646448T3 (pl) Makrocykliczne inhibitory kinazy
SI2721009T1 (sl) Derivati pirazola uporabni kot inhibitorji aldosteron sintaze
GB201003949D0 (en) Inhibitors of protein kinases
GB201018597D0 (en) Inhibitors
GB201010218D0 (en) Corrosion inhibitor